During the past decade, Carolina Heart Specialists conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolina Heart Specialists" #1 sponsor was "Bayer" with 3 trials, followed by "Biotronik, Inc." with 3 trials sponsored, "Aziyo Biologics, Inc." with 2 trials sponsored, "Zoll Medical Corporation" with 2 trials sponsored and "American Regent, Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina Heart Specialists" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Qmed Consulting A/S" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Carolina Heart Specialists" are "Heart Failure" (4 trials), "Implantable Defibrillator User" (2 trials), "Arrhythmias, Cardiac" (1 trials), "Atrial Fibrillation" (1 trials) and "Bradycardia" (1 trials). Many other conditions were trialed in "Carolina Heart Specialists" in a lesser frequency.

Most popular intervention types in "Carolina Heart Specialists" are "Device" (5 trials), "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolina Heart Specialists" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Carolina Heart Specialists". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Carolina Heart Specialists, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Carolina Heart Specialists, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".